
BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8%
Ds Sincerus Florida. LLC. Advese reactions d Active, inactive f NDC 72934- 1027-2 BRIMONIDINE TARTRATE USP 0.25%. Gel 30gm d.
Ds Sincerus Florida. LLC. Advese reactions d Active, inactive f NDC 72934- 1027-2 BRIMONIDINE TARTRATE USP 0.25%. Gel 30gm d.
Cs Sincerus Florida. LLC. Adverse reactions zx Active, inactive ed NDC 72934- 4029-3 CALCIPOTRIENE USP 0.005% / CLOBETASOL PROPIONATE USP 0.05%. Solution 60 gm xc.
C zc Active, inactive axs NDC 72934-2030-2 CALCIPOTRIENE USP 0.005% / DICLOFENAC SODIUM USP 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE USP 2%. Cream 30 gm ds.
Qd Sincerus Florida. LLC. Adverse reactions s Active, inactive sd NDC 72934- 2033-2 CALCIPOTRIENE 0.005% / NIACINAMIDE 4%. Cream 30gm c.
A Sincerus Florida. LLC .Adverse reactions c Active, inactive e NDC 72934-5034-3 CALCIPOTRIENE USP 0.005% / TRIAMCINOLONE ACETONIDE USP 0.1%. Ointment 60gm c.
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.